abstract |
The present invention relates to a compound, which specifically binds to CD38, and which is for use as a medicament for the prevention and / or treatment of a neurodegenerative disease and / or inflammatory disease, by the opening of TPC and / or TPC2 channels with two pores of the NAADP receptors, said compound activating the opening of TPC1 and / or TPC2 channels with two pores of the NAADP receptors. |